PROCEPT BioRobotics (PRCT) Cash from Operations Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -12.60% |
| 10 | PROCEPT BioRobotics | 1.20 Bn | 925.32 Mn | 62.38 Mn | -27.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.97% |
| Mar 31, 2026 | -124.54% |
| Dec 31, 2025 | 68.12% |
| Sep 30, 2025 | 64.71% |
| Jun 30, 2025 | 4.40% |
| Mar 31, 2025 | 47.41% |
| Dec 31, 2024 | -30.65% |
| Sep 30, 2024 | 0.75% |
| Jun 30, 2024 | 44.47% |
| Mar 31, 2024 | 10.14% |
| Dec 31, 2023 | 1.51% |
| Sep 30, 2023 | 4.57% |
| Jun 30, 2023 | -65.47% |
| Mar 31, 2023 | -97.07% |
| Dec 31, 2022 | -52.79% |
| Sep 30, 2022 | -55.68% |
| Jun 30, 2022 | -32.67% |
| Mar 31, 2022 | -19.96% |
| Dec 31, 2021 | -22.54% |